Anna Kathy Aman

Array ( [id] => 4746309 [patent_doc_number] => 20080090911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Stabilized prostaglandin E composition' [patent_app_type] => utility [patent_app_number] => 11/546196 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4726 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090911.pdf [firstpage_image] =>[orig_patent_app_number] => 11546196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 296108 [patent_doc_number] => 07541379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Di(amido-substituted)heteroarene compounds as osteoblastogenesis agents' [patent_app_type] => utility [patent_app_number] => 11/580170 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 5761 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541379.pdf [firstpage_image] =>[orig_patent_app_number] => 11580170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590922 [patent_doc_number] => 20100130494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'DERMATITIS TREATING AGENT (AS AMENDED)' [patent_app_type] => utility [patent_app_number] => 12/089295 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5579 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130494.pdf [firstpage_image] =>[orig_patent_app_number] => 12089295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4982479 [patent_doc_number] => 20070087037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'STIMULATION OF CPT-1 AS A MEANS TO REDUCE WEIGHT' [patent_app_type] => utility [patent_app_number] => 11/537968 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5038 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087037.pdf [firstpage_image] =>[orig_patent_app_number] => 11537968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634542 [patent_doc_number] => 08012994 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-09-06 [patent_title] => 'Method for the treatment of sensorineural hearing loss with donepezil hydrochloride (ARICEPT®)' [patent_app_type] => utility [patent_app_number] => 11/525416 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7462 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012994.pdf [firstpage_image] =>[orig_patent_app_number] => 11525416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5131631 [patent_doc_number] => 20070208028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Partial mGluR5 antagonists for treatment of anxiety and CNS disorders' [patent_app_type] => utility [patent_app_number] => 11/523873 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9274 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20070208028.pdf [firstpage_image] =>[orig_patent_app_number] => 11523873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693921 [patent_doc_number] => 20070015765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Novel methods for inhibiting angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/522238 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10024 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015765.pdf [firstpage_image] =>[orig_patent_app_number] => 11522238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 864871 [patent_doc_number] => 07368441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions' [patent_app_type] => utility [patent_app_number] => 11/468605 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2593 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368441.pdf [firstpage_image] =>[orig_patent_app_number] => 11468605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772630 [patent_doc_number] => 20080058289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'INCREASING ATP AVAILABILITY BY INHIBITION OF CREATINE KINASE (CK) LEAKAGE RESULTING FROM HIGH-INTENSITY EXERCISE' [patent_app_type] => utility [patent_app_number] => 11/468657 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2318 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058289.pdf [firstpage_image] =>[orig_patent_app_number] => 11468657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643335 [patent_doc_number] => 20060281790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Combination' [patent_app_type] => utility [patent_app_number] => 11/508353 [patent_app_country] => US [patent_app_date] => 2006-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4859 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281790.pdf [firstpage_image] =>[orig_patent_app_number] => 11508353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840340 [patent_doc_number] => 20080280826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Methods for Bone Treatment by Modulating an Arachidonic Acid Metabolic or Signaling Pathway' [patent_app_type] => utility [patent_app_number] => 11/995529 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14139 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280826.pdf [firstpage_image] =>[orig_patent_app_number] => 11995529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5153966 [patent_doc_number] => 20070036849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'USE OF PHOSPHOLIPID ARACHIDONIC ACIDS FOR INCREASING MUSCLE MASS IN HUMANS' [patent_app_type] => utility [patent_app_number] => 11/501431 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3212 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036849.pdf [firstpage_image] =>[orig_patent_app_number] => 11501431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431750 [patent_doc_number] => 20100152162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'THERAPEUTIC AND/OR PREVENTIVE AGENTS FOR A SLEEP DISORDER' [patent_app_type] => utility [patent_app_number] => 11/997585 [patent_app_country] => US [patent_app_date] => 2006-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79541 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152162.pdf [firstpage_image] =>[orig_patent_app_number] => 11997585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625976 [patent_doc_number] => 20060264481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Therapeutic modulation of PPARgamma activity' [patent_app_type] => utility [patent_app_number] => 11/493131 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72366 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264481.pdf [firstpage_image] =>[orig_patent_app_number] => 11493131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 864946 [patent_doc_number] => 07368469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events' [patent_app_type] => utility [patent_app_number] => 11/490061 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9061 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368469.pdf [firstpage_image] =>[orig_patent_app_number] => 11490061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4470179 [patent_doc_number] => 07943623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo [2,1-B] oxazole derivatives' [patent_app_type] => utility [patent_app_number] => 11/996699 [patent_app_country] => US [patent_app_date] => 2006-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5307 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943623.pdf [firstpage_image] =>[orig_patent_app_number] => 11996699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777963 [patent_doc_number] => 08853168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Compositions for the reversible thioesterification of signaling proteins and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/488992 [patent_app_country] => US [patent_app_date] => 2006-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11669 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11488992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6030844 [patent_doc_number] => 20110081300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Methods and composition for treating a material' [patent_app_type] => utility [patent_app_number] => 11/486736 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11131 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081300.pdf [firstpage_image] =>[orig_patent_app_number] => 11486736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154872 [patent_doc_number] => 20070037755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors' [patent_app_type] => utility [patent_app_number] => 11/485773 [patent_app_country] => US [patent_app_date] => 2006-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6596 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037755.pdf [firstpage_image] =>[orig_patent_app_number] => 11485773 [rel_patent_id] =>[rel_patent_doc_number] =>)